What are Neuroprotective agent combination drugs?

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Neuroprotective agent combination drugs are pharmacologic agents that share a common mechanism. 0 are currently marketed, with 1 more in clinical development.

Neuroprotective agent combination

0 marketed 1 in Phase 3

This page covers all Neuroprotective agent combination drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds.

Phase 3 pipeline (1)

Edaravone Dexborneol Sequential Therapy · Simcere Pharmaceutical Co., Ltd · Neurology
Edaravone reduces oxidative stress and neuroinflammation while dexborneol enhances cerebral blood flow and neuroprotection in a sequential combination therapy.

Patent intelligence

neuroprotective agent combination patent landscape — aggregated cliff calendar, attackable patents, originator estates